Your browser doesn't support javascript.
loading
Increased risk of urinary tract infection and pyelonephritis under concomitant use of sodium-dependent glucose cotransporter 2 inhibitors with antidiabetic, antidyslipidemic, and antihypertensive drugs: An observational study.
Tada, Keisuke; Gosho, Masahiko.
Affiliation
  • Tada K; Biostatistics & Programming, Sanofi K.K, Tokyo Opera City Tower, Tokyo, Japan.
  • Gosho M; Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki, Japan.
Fundam Clin Pharmacol ; 36(6): 1106-1114, 2022 Dec.
Article in En | MEDLINE | ID: mdl-35484899

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyelonephritis / Urinary Tract Infections / Diabetes Mellitus, Type 2 / Dipeptidyl-Peptidase IV Inhibitors / Sodium-Glucose Transporter 2 Inhibitors Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Fundam Clin Pharmacol Journal subject: FARMACOLOGIA Year: 2022 Type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyelonephritis / Urinary Tract Infections / Diabetes Mellitus, Type 2 / Dipeptidyl-Peptidase IV Inhibitors / Sodium-Glucose Transporter 2 Inhibitors Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Fundam Clin Pharmacol Journal subject: FARMACOLOGIA Year: 2022 Type: Article Affiliation country: Japan